BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND PTPRC, LCA, 5788, ENSG00000081237, T200, GP180, B220, LY5, CD45 AND Treatment
35 results:

  • 1. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
    Zhao S; Li Y; Xu J; Shen L
    Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Cell Therapy by Mesenchymal Stromal Cells Versus Myoblasts in a Pig Model of Urinary Incontinence.
    Knoll J; Amend B; Harland N; Isser S; Bézière N; Kraushaar U; Stenzl A; Aicher WK
    Tissue Eng Part A; 2024 Jan; 30(1-2):14-30. PubMed ID: 37933911
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Exosomes derived from mesenchymal stem cells loaded with annexin A2 reduce the polarization of M2 macrophages to inhibit the growth of prostate cancer cells in nude mice].
    Tian Y; Guo X; Cheng J; Wang P
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Feb; 39(2):109-116. PubMed ID: 36872428
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Biosensors for circulating tumor cells (CTCs)-biomarker detection in lung and prostate cancer: Trends and prospects.
    Hussain SH; Huertas CS; Mitchell A; Deman AL; Laurenceau E
    Biosens Bioelectron; 2022 Feb; 197():113770. PubMed ID: 34768065
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Identifying Risk Profiles of Malignant prostate cancer Surgical Delay Using a Person-Centered Approach to Understand prostate cancer Disparities: The Constellation of Health Determinants Using Latent Class Analysis on cancer Registry Data.
    Montiel Ishino FA; Rowan C; Das R; Thapa J; Cobran E; Whiteside M; Williams F
    Am J Mens Health; 2020; 14(6):1557988320984282. PubMed ID: 33372564
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The intraprostatic immune environment after stereotactic body radiotherapy is dominated by myeloid cells.
    Nickols NG; Ganapathy E; Nguyen C; Kane N; Lin L; Diaz-Perez S; Nazarian R; Mathis C; Felix C; Basehart V; Zomorodian N; Kwak J; Kishan AU; King CR; Kupelian PA; Rettig MB; Steinberg ML; Cao M; Knudsen BS; Chu FI; Romero T; Elashoff D; Reiter RE; Schaue D
    Prostate Cancer Prostatic Dis; 2021 Mar; 24(1):135-139. PubMed ID: 32647353
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Determination of the androgen receptor status of circulating tumour cells in metastatic breast cancer patients.
    Krawczyk N; Neubacher M; Meier-Stiegen F; Neubauer H; Niederacher D; Ruckhäberle E; Mohrmann S; Hoffmann J; Kaleta T; Banys-Paluchowski M; Reinecke P; Esposito I; Janni W; Fehm T
    BMC Cancer; 2019 Nov; 19(1):1101. PubMed ID: 31718606
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. New therapy with XLQ
    Yang F; Meng L; Han P; Chen D; Wang M; Jiang Y; Wu Y; Wu Y; Xing N
    J Cell Physiol; 2019 Aug; 234(10):17570-17577. PubMed ID: 30790289
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Immune infiltrates and PD-L1 expression in treatment-naïve acinar prostatic adenocarcinoma: an exploratory analysis.
    Hahn E; Liu SK; Vesprini D; Xu B; Downes MR
    J Clin Pathol; 2018 Nov; 71(11):1023-1027. PubMed ID: 30257853
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. An Improved
    Mangir N; Raza A; Haycock JW; Chapple C; Macneil S
    In Vivo; 2018; 32(3):461-472. PubMed ID: 29695547
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Analogous detection of circulating tumor cells using the AccuCyte
    van der Toom EE; Groot VP; Glavaris SA; Gemenetzis G; Chalfin HJ; Wood LD; Wolfgang CL; de la Rosette JJMCH; de Reijke TM; Pienta KJ
    Prostate; 2018 Mar; 78(4):300-307. PubMed ID: 29285777
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Identification of mechanisms of resistance to treatment with abiraterone acetate or enzalutamide in patients with castration-resistant prostate cancer (CRPC).
    Pal SK; Patel J; He M; Foulk B; Kraft K; Smirnov DA; Twardowski P; Kortylewski M; Bhargava V; Jones JO
    Cancer; 2018 Mar; 124(6):1216-1224. PubMed ID: 29266182
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The fibroblast surface markers FAP, anti-fibroblast, and FSP are expressed by cells of epithelial origin and may be altered during epithelial-to-mesenchymal transition.
    Kahounová Z; Kurfürstová D; Bouchal J; Kharaishvili G; Navrátil J; Remšík J; Šimečková Š; Študent V; Kozubík A; Souček K
    Cytometry A; 2018 Jul; 93(9):941-951. PubMed ID: 28383825
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Analysis of DNA methylation in single circulating tumor cells.
    Pixberg CF; Raba K; Müller F; Behrens B; Honisch E; Niederacher D; Neubauer H; Fehm T; Goering W; Schulz WA; Flohr P; Boysen G; Lambros M; De Bono JS; Knoefel WT; Sproll C; Stoecklein NH; Neves RPL
    Oncogene; 2017 Jun; 36(23):3223-3231. PubMed ID: 28068321
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse.
    Nardone V; Botta C; Caraglia M; Martino EC; Ambrosio MR; Carfagno T; Tini P; Semeraro L; Misso G; Grimaldi A; Boccellino M; Facchini G; Berretta M; Vischi G; Rocca BJ; Barone A; Tassone P; Tagliaferri P; Del Vecchio MT; Pirtoli L; Correale P
    Cancer Biol Ther; 2016 Nov; 17(11):1213-1220. PubMed ID: 27791459
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Method for semi-automated microscopy of filtration-enriched circulating tumor cells.
    Pailler E; Oulhen M; Billiot F; Galland A; Auger N; Faugeroux V; Laplace-Builhé C; Besse B; Loriot Y; Ngo-Camus M; Hemanda M; Lindsay CR; Soria JC; Vielh P; Farace F
    BMC Cancer; 2016 Jul; 16():477. PubMed ID: 27417942
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Licoricidin, an Active Compound in the Hexane/Ethanol Extract of Glycyrrhiza uralensis, Inhibits Lung Metastasis of 4T1 Murine Mammary Carcinoma Cells.
    Park SY; Kwon SJ; Lim SS; Kim JK; Lee KW; Park JH
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27314329
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Androgen receptor expression in circulating tumour cells from castration-resistant prostate cancer patients treated with novel endocrine agents.
    Crespo M; van Dalum G; Ferraldeschi R; Zafeiriou Z; Sideris S; Lorente D; Bianchini D; Rodrigues DN; Riisnaes R; Miranda S; Figueiredo I; Flohr P; Nowakowska K; de Bono JS; Terstappen LW; Attard G
    Br J Cancer; 2015 Mar; 112(7):1166-74. PubMed ID: 25719830
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Detection and preliminary evaluation of circulating tumor cells in the peripheral blood of patients with eight types of cancer using a telomerase-specific adenovirus.
    Yabusaki M; Sato J; Kohyama A; Kojima T; Nobuoka D; Yoshikawa T; Sawada Y; Murakami K; Gohda K; Okegawa T; Nakamura M; Takamatsu K; Ito M; Kaneko K; Nakatsura T
    Oncol Rep; 2014 Nov; 32(5):1772-8. PubMed ID: 25176113
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Surgical technique of robotic D3 lymph node dissection around the inferior mesenteric artery with preservation of the left colic artery and autonomic nerves for the treatment of distal rectal cancer.
    Liang JT; Lai HS
    Surg Endosc; 2014 May; 28(5):1727-33. PubMed ID: 24337916
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.